rs1780329

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000478.6(ALPL):​c.1190-65C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.2 in 1,585,492 control chromosomes in the GnomAD database, including 36,068 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5390 hom., cov: 31)
Exomes 𝑓: 0.19 ( 30678 hom. )

Consequence

ALPL
NM_000478.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.873

Publications

16 publications found
Variant links:
Genes affected
ALPL (HGNC:438): (alkaline phosphatase, biomineralization associated) This gene encodes a member of the alkaline phosphatase family of proteins. There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The first three are located together on chromosome 2, while the tissue non-specific form is located on chromosome 1. The product of this gene is a membrane bound glycosylated enzyme that is not expressed in any particular tissue and is, therefore, referred to as the tissue-nonspecific form of the enzyme. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature enzyme. This enzyme may play a role in bone mineralization. Mutations in this gene have been linked to hypophosphatasia, a disorder that is characterized by hypercalcemia and skeletal defects. [provided by RefSeq, Oct 2015]
ALPL Gene-Disease associations (from GenCC):
  • adult hypophosphatasia
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet
  • childhood hypophosphatasia
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, ClinGen, Orphanet
  • hypophosphatasia
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, G2P
  • infantile hypophosphatasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • odontohypophosphatasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • perinatal lethal hypophosphatasia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 1-21576457-C-A is Benign according to our data. Variant chr1-21576457-C-A is described in ClinVar as Benign. ClinVar VariationId is 1177605.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.454 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALPLNM_000478.6 linkc.1190-65C>A intron_variant Intron 10 of 11 ENST00000374840.8 NP_000469.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALPLENST00000374840.8 linkc.1190-65C>A intron_variant Intron 10 of 11 1 NM_000478.6 ENSP00000363973.3

Frequencies

GnomAD3 genomes
AF:
0.248
AC:
37615
AN:
151688
Hom.:
5377
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.350
Gnomad AMI
AF:
0.129
Gnomad AMR
AF:
0.277
Gnomad ASJ
AF:
0.158
Gnomad EAS
AF:
0.469
Gnomad SAS
AF:
0.258
Gnomad FIN
AF:
0.268
Gnomad MID
AF:
0.174
Gnomad NFE
AF:
0.166
Gnomad OTH
AF:
0.236
GnomAD4 exome
AF:
0.195
AC:
279081
AN:
1433684
Hom.:
30678
AF XY:
0.195
AC XY:
138347
AN XY:
709848
show subpopulations
African (AFR)
AF:
0.350
AC:
11493
AN:
32812
American (AMR)
AF:
0.278
AC:
11839
AN:
42596
Ashkenazi Jewish (ASJ)
AF:
0.157
AC:
3943
AN:
25078
East Asian (EAS)
AF:
0.524
AC:
20494
AN:
39098
South Asian (SAS)
AF:
0.248
AC:
20766
AN:
83756
European-Finnish (FIN)
AF:
0.250
AC:
13185
AN:
52676
Middle Eastern (MID)
AF:
0.170
AC:
862
AN:
5068
European-Non Finnish (NFE)
AF:
0.168
AC:
184143
AN:
1093610
Other (OTH)
AF:
0.209
AC:
12356
AN:
58990
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
11323
22645
33968
45290
56613
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7022
14044
21066
28088
35110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.248
AC:
37670
AN:
151808
Hom.:
5390
Cov.:
31
AF XY:
0.254
AC XY:
18830
AN XY:
74202
show subpopulations
African (AFR)
AF:
0.350
AC:
14474
AN:
41332
American (AMR)
AF:
0.278
AC:
4240
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.158
AC:
548
AN:
3470
East Asian (EAS)
AF:
0.470
AC:
2407
AN:
5124
South Asian (SAS)
AF:
0.257
AC:
1237
AN:
4812
European-Finnish (FIN)
AF:
0.268
AC:
2835
AN:
10562
Middle Eastern (MID)
AF:
0.177
AC:
52
AN:
294
European-Non Finnish (NFE)
AF:
0.166
AC:
11251
AN:
67924
Other (OTH)
AF:
0.241
AC:
508
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1358
2715
4073
5430
6788
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
370
740
1110
1480
1850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.204
Hom.:
5453
Bravo
AF:
0.253
Asia WGS
AF:
0.356
AC:
1238
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 20, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Infantile hypophosphatasia Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Adult hypophosphatasia Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Childhood hypophosphatasia Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.5
DANN
Benign
0.75
PhyloP100
-0.87
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1780329; hg19: chr1-21902950; COSMIC: COSV66376181; API